1.Alkan A, Kutlu R, Aslan M, Sigirci A, Orkan I, Yakinci C: Pyridoxine-dependent seizures: magnetic resonance spectroscopy findings. J Child Neurol 2004, 19(1):75–78.
2.Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ: Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 1983, 309(8):445–448.
3.Perry TA, Weerasuriya A, Mouton PR, Holloway HW, Greig NH: Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy. Exp Neurol 2004, 190(1):133–144.
4.Krinke GJ, Fitzgerald RE: The pattern of pyridoxine-induced lesion: difference between the high and the low toxic level. Toxicology 1988, 49(1):171–178.
5.Krinke G, Naylor DC, Skorpil V: Pyridoxine megavitaminosis: an analysis of the early changes induced with massive doses of vitamin B6 in rat primary sensory neurons. J Neuropathol Exp Neurol 1985, 44(2):117–129.
6.Xu Y, Sladky JT, Brown MJ: Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology 1989, 39(8):1077–1083.
7.Chung JY, Choi JH, Hwang CY, Youn HY: Pyridoxine induced neuropathy by subcutaneous administration in dogs. J Vet Sci 2008, 9(2):127–131.
8.Hoover DM, Carlton WW: The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro–7-iodo–8-hydroxyquinoline) in beagle dogs. I. Clinical disease. Vet Pathol 1981, 18(6):745–756.
9.Schaeppi U, Krinke G: Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6. Agents Actions 1982, 12(4):575–582.
10.Albin RL, Albers JW, Greenberg HS, Townsend JB, Lynn RB, Burke JM, Jr., Alessi AG: Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology 1987, 37(11):1729–1732.
11.Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL: Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 2007, 68(7):515–521.
12.Cohen JS: Peripheral neuropathy associated with fluoroquinolones. Ann Pharmacother 2001, 35(12):1540–1547.
13.Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ: Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 1997, 49(6):1635–1640.
14.Willis WD, Jr.: Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp Brain Res 1999, 124(4):395–421.
15.Callizot N, Warter JM, Poindron P: Pyridoxine-induced neuropathy in rats: a sensory neuropathy that responds to 4-methylcatechol. Neurobiol Dis 2001, 8(4):626–635.
16.Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR: Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 1994, 35(3):304–311.
17.Hopkins AP, Gilliatt RW: Motor and sensory nerve conduction velocity in the baboon: normal values and changes during acrylamide neuropathy. J Neurol Neurosurg Psychiatry 1971, 34(4):415–426.
18.Dahl D, Bignami A: Intermediate filaments in nervous tissue. Cell Muscle Motil 1985, 6:75–96.
19.Pekny M, Pekna M: Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 2004, 204(4):428–437.